久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

<nav id="6om05"></nav>

You are here: Industry Insights > Paxlovid

News List

Pfizer seeks EUA for Covid-19 antiviral pill in US Pharmaceutical-Business-Review
November 18, 2021
Pfizer has submitted an application to the US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of its investigational oral antiviral drug, Paxlovid (PF-07321332; ritonavir).
Pfizer seeks FDA EUA for oral antiviral pill to treat Covid-19 Pharmaceutical-Technology
November 18, 2021
Pfizer has sought Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its experimental oral antiviral pill, Paxlovid (PF-07321332; ritonavir), to treat individuals with mild-to-moderate Covid-19.
Oral antiviral candidate Paxlovid? reduces COVID-19 risks by 89 percent EuropeanPharmaceuticalReview
November 09, 2021
Pfizer has announced its investigational novel COVID-19 oral antiviral candidate, Paxlovid?, significantly reduced hospitalisation and death, based on an interim analysis of the Phase II/III EPIC-HR randomised...